lting, MNTA was only one participant in a lawsuit against TEVA challenging their patents. There has been no product launch by MNTA or I believe by any of the litigants. Why would there be any damages?
No, because (as vinmantoo noted), MNTA has not sold any product in violation of Teva’s Copaxone patents. Still, the lawsuit has incurred implicit damages insofar as MNTA has had to pay a portion of the legal expenses.
Market Data 
Markets 
AI
